Swiss National Bank
PRME icon

Swiss National Bank’s Prime Medicine PRME Stock Holding History

Swiss National Bank’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
208,300
+29,700
+17% +$98.6K ﹤0.01% 2252
2026
Q1 		$622K Buy
178,600
+8,500
+5% +$32.4K ﹤0.01% 2251
2025
Q4 		$590K Buy
+170,100
New +$757K ﹤0.01% 2270
2023
Q2 		– Sell
-41,900
Closed -$515K – 2645
2023
Q1 		$515K Buy
+41,900
New +$683K ﹤0.01% 2512

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Swiss National Bank's PRME Position: Q2 2026 in Review

Swiss National Bank increased its Prime Medicine (PRME) stake by 17% in Q2 2026, buying an estimated $98.6K and bringing the position to 208,300 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Swiss National Bank first reported a position in PRME in Q1 2023 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Swiss National Bank held 208,300 shares of Prime Medicine worth $769K as of Q2 2026.
  • Swiss National Bank bought 29,700 Prime Medicine shares in Q2 2026, an estimated $98.6K.
  • Prime Medicine made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2252 holding.
  • Swiss National Bank first reported a position in Prime Medicine in Q1 2023 and has held it in 4 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.